Can I Take Semaglutide for Weight Loss? Complete Guide

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, originally developed for type 2 diabetes, has emerged as a powerful weight loss medication that reduces appetite and slows stomach emptying, helping patients shed 15–22% of body weight in clinical trials. If you're wondering whether semaglutide is appropriate for your situation, this guide breaks down eligibility, how the medication works, and how PlexusDx delivers compounded semaglutide injections directly to you.

Who Can Take Semaglutide for Weight Loss

Semaglutide is indicated for chronic weight management in adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have weight-related health conditions such as hypertension, type 2 diabetes, or heart disease. Your medical history matters: semaglutide is not recommended if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). A consultation with a healthcare provider helps determine whether your medical profile aligns with safe semaglutide use.

Pregnancy and breastfeeding are contraindications because animal studies show potential fetal risk. If you have a history of pancreatitis, gallbladder disease, or severe gastrointestinal problems, your provider should weigh the risks and benefits carefully. PlexusDx pairs every patient with qualified providers who review your full health history before starting treatment, ensuring semaglutide is appropriate for your unique circumstances.

How Semaglutide Works to Reduce Appetite and Weight

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your gut releases after eating. When semaglutide binds to GLP-1 receptors in your brain's appetite center, it sends signals that you feel fuller longer, reducing hunger between meals. The medication also slows how quickly food moves through your stomach, which extends the feeling of fullness and naturally lowers calorie intake without requiring willpower or severe food restriction.

Clinical trials demonstrate that patients on semaglutide lose weight consistently over 68 weeks, with many experiencing a 15–22% reduction in body weight compared to 2–3% in the placebo group. Beyond appetite suppression, semaglutide can improve blood sugar control and reduce cardiovascular risk, making it beneficial for patients with multiple metabolic concerns. The effect is gradual and sustainable because it works with your body's natural hunger signals rather than stimulating your nervous system like older weight loss drugs.

Compounded Semaglutide vs. Brand-Name Ozempic® and Wegovy®

Ozempic® is FDA-approved for type 2 diabetes, while Wegovy® is the brand-name version approved for weight loss management. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, which are permitted to prepare FDA-approved active ingredients under pharmacy supervision. Compounded semaglutide contains the same active pharmaceutical ingredient as brand-name versions but is prepared in a licensed pharmacy setting rather than at a manufacturer's facility.

The key advantage is accessibility and cost: compounded semaglutide injections start at $149 per month with PlexusDx, compared to brand-name prices that often exceed $900–$1,300 monthly before insurance. Because PlexusDx requires no insurance, no membership fees, and accepts HSA/FSA funds, many patients find compounded semaglutide a more affordable path to treatment. Your dose may need to go up over time as your body adjusts, but your price won't—PlexusDx maintains flat monthly pricing across all commitment tiers.

Common Side Effects and Safety Monitoring

Mild to moderate gastrointestinal symptoms occur in 20–40% of patients starting semaglutide: nausea, vomiting, constipation, and diarrhea are most frequent. These side effects typically appear in the first few weeks and decrease as your body adapts; starting with a low dose and gradually increasing (titration) over 16–20 weeks significantly reduces nausea severity. Eating smaller, lower-fat meals and staying hydrated can minimize digestive discomfort.

Serious but rare side effects include acute pancreatitis (severe abdominal pain), gallbladder complications, and rapid heart rate. PlexusDx providers monitor your progress through check-ins and adjust your treatment if side effects become bothersome. If you experience persistent vomiting, severe abdominal pain, or signs of allergic reaction, contact your provider immediately. Most patients tolerate semaglutide well when dosed gradually and supported by a provider who tracks your response.

Getting Started With PlexusDx Compounded Semaglutide

The PlexusDx process begins with a health assessment and provider consultation to confirm semaglutide is safe for you. You'll receive your first supply of compounded semaglutide injections, which you self-administer subcutaneously (under the skin) once weekly, typically in the abdomen or thigh. After your first month, PlexusDx offers the optional Precision Peptide Genetic Test for $99, which analyzes 14 metabolic pathways and 150+ genetic insights to optimize your GLP-1 therapy based on your peptide-pathway genetics.

PlexusDx delivers to all 50 states without requiring insurance, membership, or ongoing commitments. Your semaglutide injections are prepared by licensed 503A compounding pharmacies and arrive discreetly at your door. Ongoing support includes periodic check-ins with your provider to monitor weight loss, side effects, and medication response, ensuring your treatment stays personalized as your needs evolve.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as Ozempic® or Wegovy®?

Compounded semaglutide contains the same active ingredient as brand-name versions and is prepared in a licensed 503A compounding pharmacy under strict quality standards. The main differences are cost, accessibility, and personalization: PlexusDx compounded semaglutide starts at $149/month with no insurance required, and you receive provider supp...

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 15–22% of body weight over 68 weeks, though individual results vary based on diet, exercise, medication compliance, and genetics. PlexusDx's Precision Peptide Genetic Test can reveal whether your genetic profile predicts stronger or weaker response to GLP-1 therapy, helping your provider adjust your ap...

What does PlexusDx semaglutide cost, and are there payment options?

PlexusDx compounded semaglutide injections start at $149 per month with a flat price guarantee—your dose can increase without raising your monthly cost. Pricing is the same across all commitment tiers, and HSA/FSA funds are accepted. No insurance, membership fees, or long-term contracts are required.

What are the most common side effects, and how long do they last?

Nausea, constipation, and mild vomiting occur in 20–40% of patients in the first 2–4 weeks but typically resolve as your body adapts. Gradual dose titration over 16–20 weeks significantly reduces side effects. Most patients manage mild gastrointestinal symptoms with dietary adjustments and hydration while experiencing substantial weight loss ben...

What is the PlexusDx Precision Peptide Genetic Test, and does it help with semaglutide?

The Precision Peptide Genetic Test analyzes your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways—markers that influence how your body responds to GLP-1 medications. Available for $99 after your first month of treatment, it maps 14 metabolic pathways and 150+ genetic insights to help your provider personalize your semaglutide dose and pre...

Can I Take Ozempic®? Your Guide to Semaglutide and Weight Loss